GLP1R and endometrial cancer: These data provide some insights into the molecular mechanisms involved in chemoresistance induced by hyperglycemia and demonstrate that hypoglycemic drug, GLP-1 receptor agonist-Exe-4, could help alleviate such chemoresistance in endometrial cancer.